ecancer

Comparing toxicity profiles for 72 hour infusional and conventional bleomycin in testicular cancer

Dr Jonathan Shamash - Barts Cancer Institute, London, UK

15 Nov 2013

UK fight for tobacco control

Prof Linda Bauld - University of Stirling, Stirling, UK

14 Nov 2013

Engineering of polymeric nanoparticles for medical applications

Dr Omid Farokhzad - Harvard Medical School, Boston, USA

14 Nov 2013

Editor’s Choice - ecancermedicalscience November 2013

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

14 Nov 2013

The immune microenvironment as an anti-cancer therapeutic strategy

Dr Lisa Coussens - Oregon Science & Health University, USA

12 Nov 2013

Choosing the right treatment for each patient: The emergence of personalised healthcare in non-small cell lung cancer

Dr Frances Shepherd - Princess Margaret Hospital and the University of Toronto, Canada

8 Nov 2013

The revolution in personalised healthcare: Towards improved outcomes in oncology: Conclusion and Summary

Dr Frances Shepherd - Princess Margaret Hospital and the University of Toronto, Canada

8 Nov 2013

Brain mestastases from lung cancer ECC 2013

Dr Lucio Crinò - University Hospital of Perugia, Italy

23 Oct 2013

European Cancer Congress 2013 - News Roundup

Prof Gordon Mcvie - ecancer Managing Editor and the European Institute of Oncology

22 Oct 2013

New antibody drug, MPDL3280A, in non-small cell lung cancer

Prof Jean-Charles Soria - Institut Gustave Roussy, Paris, France

3 Oct 2013

Comment on immunotherapy in lung cancer from the ECC 2013 Scientific Co-Chair

Prof Cora Sternberg - San Camillo and Forlanini Hospitals, Rome, Italy

29 Sep 2013

Results for new antibody drug in non-small cell lung cancer

Prof Jean-Charles Soria - Institut Gustave Roussy, Villejuif, France

29 Sep 2013

More from ecancer